PRCSG News

   

 PReS 2018 ABSTRACTS / POSTERS

 

  • Poster display: 07Sep2018. Poster walk: 13:15 - 14:15  The Safety Profile of Adalimumab across Geographic Regions and Dosing Administrations among Patients with Juvenile Idiopathic Arthritis enrolled in the STRIVE Registry.  Abstract number: P362. 

 

     

 NEW - Revised Common Rule: educational videos created by OHRP

 

May 2018 - FDA approves subcutaneous formulation of Actemra for use is Polyarticular Juvenile Idiopathic Arthritis

 

March 2017 - Subcutaneous abatacept now available for patients with JIA. link